COX-2 Inhibitor Use as an Early Treatment Option for Knee Osteoarthritis Patients in Korea: A Population-Based Cross-Sectional Study

BACKGROUND: To investigate the use of cyclooxygenase-2 (COX-2) inhibitors as an initial drug treatment for knee osteoarthritis (OA) patients. METHODS: From 2013 to 2015, patients with knee OA were identified from the Korean nationwide claims database. Among them, we extracted incident cases of knee...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Soo-Kyung, Choi, Seongmi, Kim, Hyoungyoung, Song, Yeo-Jin, Jung, Sun-Young, Jang, Eun Jin, Sung, Yoon-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091425/
https://www.ncbi.nlm.nih.gov/pubmed/35535375
http://dx.doi.org/10.3346/jkms.2022.37.e148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091425/
https://www.ncbi.nlm.nih.gov/pubmed/35535375
http://dx.doi.org/10.3346/jkms.2022.37.e148

Ejemplares similares